Patients with Crohn’s disease treated with certolizumab pegol experienced long-term remission regardless of prior TNF-a inhibitor exposure (PRECiSE 4 study)
- Type
- Expression of concern
- Notice date
- 1/24/2022 0:00
- Journal
- Journal of Crohn's and Colitis
- Publisher
- Oxford University Press
- Notice DOI
- 10.1093/ecco-jcc/jjab227
- Original paper DOI
- 10.1016/s1873-9946(10)00006-1